Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Infinito Gold Ltd.
Infinito Arranges $18,000,000 Convertible Note Financing To Fund Crucitas Development
September 14th, 2008
Infinito Gold Ltd. (the "Company") announces that it has agreed to complete a non-brokered private placement of an aggregate of CDN$18 million principal amount of convertible notes (the "Notes") with Exploram Enterprises Ltd. ("Exploram") and Auro Investments Ltd. ("Auro"). The Notes mature five years after their date of issue, bear interest at 11% per year, payable monthly, and are convertible at any time up to maturity into common shares of the Company at $0.635 per share, being a 15% premium to the volume weighted average trading price of the shares of the Company for the previous 10 trading days. The Company has the right to prepay the Notes, in whole or in part, at any time after 30...
Source: Pharma Investments, Ventures & Law Weekly (2008-09-14)
|
